126
Participants
Start Date
July 15, 2021
Primary Completion Date
July 26, 2023
Study Completion Date
July 26, 2023
Ociperlimab
Ociperlimab 900 milligrams (mg) administered intravenously once every 3 weeks on Day 1 of each cycle
Tislelizumab
Tislelizumab 200 mg administered intravenously once every 3 weeks on Day 1 of each cycle
Concurrent Chemoradiotherapy
"Cisplatin/Carboplatin: Either cisplatin 75 milligrams/meters squared (mg/m2) administered intravenously once every 3 weeks on Day 1 of each cycle for 4 cycles or carboplatin at a dose of area under the curve (AUC) 5 administered intravenously once every 3 weeks on Day 1 of each cycle for 4 cycles.~Etoposide: (100 mg/m2) administered intravenously on Days 1, 2, and 3 of each cycle for 4 cycles~Thoracic radiation therapy (TRT): once daily fractions for 6 to 7 weeks for a total dose of 60 to 70 units of absorbed dose of ionizing radiation (Gy)"
Cha Bundang Medical Center, Cha University, Gyeonggido
The Catholic University of Korea, St Vincents Hospital, Suwon
Ajou University Hospital, Suwon
Chungbuk National University Hospital, Cheongju-si
Tennessee Cancer Specialist, Knoxville
Kyungpook National University Chilgok Hospital, Daegu
Hanzhong Central Hospital, Hanzhong
Peking University First Hospital, Beijing
Beijing Cancer Hospital, Beijing
Fudan University Shanghai Cancer Center, Shanghai
Affiliated Zhongshan Hospital of Fudan University, Shanghai
Nanjing Chest Hospital, Nanjing
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
Huai An First Peoples Hospital, Huaian
Qilu Hospital of Shandong University, Jinan
Yantai Yuhuangding Hospital, Yantai
Qingdao Central Hospital, Qingdao
Linyi Cancer Hospital, Linyi
Tianjin Medical University General Hospital, Tianjin
Tianjin Medical University Cancer Institute and Hospital, Tianjin
Zhejiang Cancer Hospital, Hangzhou
Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No Hospital), Ningbo
The Second Xiangya Hospital of Central South University, Changsha
Hunan Cancer Hospital, Changsha
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
The First Affiliated Hospital, Sun Yat Sen University, Guangzhou
The Tumor Hospital Affiliated to Guangxi Medical University, Nanning
West China Hospital, Sichuan University, Chengdu
Affiliated Hospital of North Sichuan Medical College, Nanchong
The Second Affiliated Hospital of Kunming Medical University, Kunming
Gansu Provincial Cancer Hospital, Lanzhou
Lead Sponsor
BeiGene
INDUSTRY